Famicordtx S.A. announced that it has received €3.5 million in funding from NextCell Pharma AB, Polski Bank Komórek Macierzystych S.A. and other investors

Famicordtx S.A. announced that it has received €3,000,000 in an equity round of funding on February 8, 2022. The transaction included participation from returning investors NextCell Pharma AB, Polski Bank Komórek Macierzystych S.A. in 50% of pro rata and other investors. As part of the transaction, NextCell Pharma AB, invested approximately €160,000 and a change of stake from 9.43% to 8.45% stake in the company.